Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: A randomized trial

American Journal of Transplantation

Volumn 12, Issue 3, 2012, Pages 694-705

  Abdelmalek, M F ^a,n   Humar, A ^b,o   Stickel, F ^c   Andreone, P ^d   Pascher, A ^e   Barroso, E ^f   Neff, G W ^g   Ranjan, D ^h   Toselli, L T ⁱ   Gane, E J ^j   Scarola, J ^k   Alberts, R G ^l   Maller, E S ^l   Lo, C M ^m  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f HOSPITAL CURRY CABRAL   (Portugal)

^g UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^h UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

ⁱ CRAI Norte   (Argentina)

^j AUCKLAND CITY HOSPITAL   (New Zealand)

^k PFIZER INC   (United States)

^l Pfizer Vaccine Research Statistics   (United States)

^m QUEEN MARY HOSPITAL   (Hong Kong)

ⁿ DUKE UNIVERSITY   (United States)

^o UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

Calcineurin inhibitor; liver transplantation; maintenance therapy; nephrotoxicity; sirolimus

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACNE; ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGRAFT; ANEMIA; ARTICLE; ASTHENIA; CAUSE OF DEATH; CREATININE BLOOD LEVEL; DIARRHEA; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEADACHE; HEPATITIS; HERPES SIMPLEX; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEOPLASM; NEPHROTOXICITY; OPEN STUDY; ORGAN TRANSPLANTATION; PAIN; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZATION; RASH; SEPSIS; SIDE EFFECT; SKIN CARCINOMA; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CALCINEURIN; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84857648997     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03919.x     Document Type: Article

References (22)

1. Hong JC, Kahan BD,. Immunosuppressive agents in organ transplantation: Past, present, and future. Semin Nephrol 2000; 20: 108-125. (Pubitemid 30158481)
2. Monsour HP, Jr., Wood RP, Dyer CH, Galati JS, Ozaki CF, Clark JH,. Renal insufficiency and hypertension as long-term complications in liver transplantation. Semin Liver Dis 1995; 15: 123-132.
3. Platz KP, Mueller AR, Blumhardt G, et al,. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994; 7 (Suppl 1): S52-S57.
4. Wiesner R, Klintmalm G, McDiarmid S, Rapamune Liver Transplant Study Group Sirolimus immunotherapy results in reduced rates of acute rejection in de novo orthotopic liver transplant recipients [abstract 1294]. Am J Transplant 2002; 2: 464.
5. Gonwa TA, Mai ML, Melton LB, et al,. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 1934-1939. (Pubitemid 34027867)
6. Di Benedetto F, Di SS, De RN, et al,. Immunosuppressive switch to sirolimus in renal dysfunction after liver transplantation. Transplant Proc 2009; 41: 1297-1299.
7. Di Benedetto F, Di SS, De RN, et al,. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. J Clin Gastroenterol 2009; 43: 280-286.
8. Schena FP, Pascoe MD, Alberu J, et al,. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 2009; 87: 233-242.
9. Cotterell AH, Fisher RA, King AL, et al,. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. Clin Transplant 2002; 16 (Suppl 7): 49-51. (Pubitemid 41185585)
10. Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ,. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003; 9: 1079-1085. (Pubitemid 37304464)
11. Heffron TG, Smallwood GA, Davis L, Martinez E, Stieber AC,. Sirolimus-based immunosuppressive [correction of immunosuppresive] protocol for calcineurin sparing in liver transplantation. Transplant Proc 2002; 34: 1522-1523.
12. Nair S, Eason J, Loss G,. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transpl 2003; 9: 126-129. (Pubitemid 36204562)
13. Neff GW, Montalbano M, Slapak-Green G, et al,. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant Proc 2003; 35: 3029-3031. (Pubitemid 38102122)
14. Sanchez EQ, Martin AP, Ikegami T, et al,. Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Transplant Proc 2005; 37: 4416-4423. (Pubitemid 43016046)
15. Wadei HM, Mai M, Ahsan N, Rosser BG, Gonwa TA,. High risk of proteinuria and lack of improvement of kidney function following sirolimus conversion in liver transplant recipients [abstract 1370]. Am J Transplant 2008; 8: 543.
16. Shaikh TA, Sterling RK, Shiffman ML, Fisher RA, Cotterell AH, Maluf DG,. Adverse effects and poor tolerance of sirolimus (SIR) in liver transplant recipients [abstract 480]. Am J Transplant 2008; 2 (Suppl 2): 307.
17. Shenoy S, Hardinger KL, Crippin J, et al,. Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation 2007; 83: 1389-1392. (Pubitemid 46800318)
18. Watson CJ, Gimson AE, Alexander GJ, et al,. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007; 13: 1694-1702.
19. Cockroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
20. Ojo AO, Held PJ, Port FK, et al,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940. (Pubitemid 37064766)
21. Sanchez EQ, Melton LB, Chinnakotla S, et al,. Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation 2010; 89: 232-235.
22. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB, Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-309. (Pubitemid 38240131)